Article

Bilateral temporal glioma presenting as a paraneoplastic limbic encephalitis with pure cognitive impairment.

Department of Neurology and Memory Clinic, University Hospital of Lille and Lille II University, France.
The Neurologist (Impact Factor: 1.48). 08/2009; 15(4):208-11. DOI: 10.1097/NRL.0b013e31818fc022
Source: PubMed

ABSTRACT Memory impairment caused by bilateral hippocampal primitive brain tumor is rarely reported. Clinical and MRI features can mimic paraneoplastic limbic encephalitis (PLE), and the differential diagnosis between these 2 entities may be difficult.
We report the case of a 42-year-old woman presenting with amnesia without neurologic focal signs at clinical examination. The neuroimaging features consisted of bilateral limbic hyperintensities on T2-weighted and FLAIR brain MRI. Despite exhaustive biologic and radiologic investigations, no specific etiology was found. The diagnosis of paraneoplastic limbic encephalitis was suspected, although antineuronal antibodies were negative and no cancer was detected after the first evaluation. Eight months after onset, the memory complaint of the patient increased along with disability in activities of the daily living, the neurologic examination slightly changed with frontal neurologic signs and the brain MRI showed a new cystic lesion in the left hippocampus with enhancement after contrast administration. The left temporal tumor was resected and the neuropathological examination was consistent with gliomatosis cerebri with a focal high grade astrocytoma.
This case highlights the need to consider the possibility of infiltrative gliomatosis in patients presenting with features of paraneoplastic limbic encephalitis.

0 Bookmarks
 · 
114 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: We describe the clinical features of limbic encephalitis that developed after palliative spinal cordotomy in 2 patients with malignant thoracic astrocytoma. Both patients showed short-term memory loss, hallucinations of smells and psychiatric symptoms. Brain MRI on T2-weighted and fluid-attenuated inversion recovery sequences revealed high intensity lesions in bilateral temporal lobe areas. We considered that both patients had paraneoplastic limbic encephalitis associated with astrocytoma because of various clinical and radiological features. But the possibility of intracranial dissemination of astrocytoma could not be fully excluded. The differential diagnosis between intracranial dissemination of spinal cord astrocytoma and paraneoplastic limbic encephalitis may be sometimes difficult.
    Internal Medicine 01/2012; 51(3):321-4. · 0.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paraneoplastic neurological syndromes (PNSs) cover a wide range of diseases and involve both the central nervous system (CNS) and peripheral nervous system. Paraneoplastic encephalitis comprises several diseases such as paraneoplastic cerebellar degeneration (PCD), limbic encephalitis (LE), paraneoplastic encephalomyelitis (PEM), brainstem encephalitis, opsomyoclonus syndrome, in addition to other even less frequently occurring entities. LE was the first historically identified CNS PNS, and similarities between other temporal lobe diseases such as herpes encephalitis have been elucidated. In the past few decades several autoantibodies have been described in association with LE. These encompass the classical 'onconeuronal' antibodies (abs) such as Hu, Yo, Ri and others, and now additionally abs towards either ion channels or surface antigens. The clinical core findings in LE are various mental changes such as amnesia or confusion, often associated with seizures. Careful characterization of psychiatric manifestations and/or associated neurological signs can help to characterize the syndrome and type of ab. The treatment options in LE depend on the aetiology. In LE caused by onconeuronal abs, the treatment options are poor. In two types of abs associated with LE, abs against ion channels and surface antigens (e.g. NMDA), immunomodulatory treatments seem effective, making these types of LE treatable conditions. However, LE can also occur without being associated with cancer, in which case only immunomodulation is required. Despite effective treatments, some patients' residual deficits remain, and recurrences have also been described.
    Therapeutic Advances in Neurological Disorders 07/2011; 4(4):237-48.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Les démences représentent un problème de santé public majeur, notamment du fait du vieillissement des populations occidentales. Pourtant, le diagnostic étiologique de certitude d'un syndrome démentiel ne peut être obtenu que par l'analyse neuropathologique et/ou biochimique du tissu cérébral obtenu en post mortem. Les lésions cérébrales aboutissant au déclin cognitif ont des origines diverses (neurodégénératives, vasculaires, métaboliques...) et sont souvent associées. En analysant les données cliniques, neuropathologiques et biochimique issues de la cohorte autopsiques de patients déments suivis au Centre Mémoire de Ressources et de recherche du CHRU de Lille (127 cerveaux prélevés entre 1992 et 2009), nous avons étudié les corrélations entre l'expression clinique du syndrome démentiel et la nature des lésions cérébrales sous jacentes. Nous montrons que les fréquentes associations lésionnelles (lésions de maladie d'Alzheimer, de maladie à corps de Lewy, lésions vasculaires) ont des conséquences sur la pertinence du diagnostic étiologique du syndrome démentiel. Dans le domaine des dégénérescences lobaires frontotemporales (DLFT), nous avons étudié les corrélations clinicopathologiques de 18 patients ayant présenté des troubles inauguraux du langage ou de la parole. Nous avons pu établir des corrélations entre les syndromes cliniques et certaines protéinopathies (tau, TDP-43) associées aux DLFT. L'enquête génétique a permis de mettre en évidence une nouvelle mutation du gène de la progranuline chez un patient. L'analyse pluridisciplinaire des démences permet au clinicien de progresser dans la prédiction des lésions cérébrales du vivant du patient. Cette démarche s'avère indispensable dans l'optique du développement de traitements curatifs des démences neurodégénératives.

Full-text

View
18 Downloads
Available from
May 21, 2014